Found 66 matching trials
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases EARLY_PHASE1 This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Learn More & Join Trial
Universal CAR-T Cells Targeting Multiple Myeloma PHASE1 The aim of this study is to assess the feasibility, safety and efficacy of ...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma PHASE1 This is a Phase 1, multicenter, open-label study o evaluate the safety and ...
Show More Location
Hematology Department of the First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH PHASE1 This is a single-center, open-label, non-randomized, single-arm clinical tr...
Show More Location
ćäșŹé«ćć»éą
Learn More & Join Trial
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. PHASE1 This is a single-center, open-label, non-randomized, single-arm clinical tr...
Show More Location
Beijing GoBroad Hospital
Learn More & Join Trial
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia PHASE2 This is a single-arm, open-label study to evaluate the efficacy and safety ...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
the Safety and Efficacy of SENL103 Autologous T Cell Injection EARLY_PHASE1 To observe the safety and efficacy of SENL103 cells in the treatment of pat...
Show More Learn More & Join Trial
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma PHASE3 The goal of this study (iMMagine-3) is to compare the study drug, anitocabt...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
CAR-T Cell Therapy for Desensitization in Kidney Transplantation PHASE1 This research study is for people who have been waiting for a kidney transp...
Show More Location
Massachusetts General Hospital: Transplantation (Site #: 71107)
Learn More & Join Trial